| http://www.w3.org/ns/prov#value | - With the big increase in production, analysts had expected more than $300 million in revenue from Fluvirin this year.Vaccine Remains PriorityChiron, anticipating higher revenue, had increased spending in research and development and other areas of its business.
|
